Concepedia

J. Ro

JR

Statistics

Publications

3

Citations

68

H-Index

3

Active since

2009

Affiliations

Saint Francis Hospital & Medical Center(Current)

J. Ro is an author at Saint Francis Hospital & Medical Center specializing in oncology, metastatic breast cancer, and metastatic breast cancer treatment.

Publications per year

2009–2014

3

Publications

3

Final Overall Survival (Os) Analysis from the Cleopatra Study of First-Line (1L) Pertuzumab (Ptz), Trastuzumab (T), and Docetaxel (D) in Patients (Pts) with Her2-Positive Metastatic Breast Cancer (Mbc)

Sandra M. Swain, S. Kim, Javier Cortés et al. · Annals of Oncology · 2014 · 37 citations · Full text

, , +16

S5-7: A Phase 2, Randomized, Open-Label, Study of Neratinib (HKI-272) vs Lapatinib Plus Capecitabine for 2nd/3rd-Line Treatment of HER2+ Locally Advanced or Metastatic Breast Cancer.

M Martín, Jacques Bonneterre, CE Geyer et al. · Cancer Research · 2011 · 18 citations

, , +17

Ixabepilone plus capecitabine improves progression free survival in patients with metastatic breast cancer resistant to taxanes: a pooled analysis from two phase III trials.

Henri Roché, R Li, J. Ro et al. · Cancer Research · 2009 · 13 citations · Full text

, , +16

1–3 of 3